Antispasmodics for labour

Cochrane Database of Systematic Reviews

Volumn 2013, Issue 6, 2013, Pages

  Rohwer, Anke C ^a   Khondowe, Oswell ^a   Young, Taryn ^a,b  

^a UNIVERSITY OF STELLENBOSCH   (South Africa)

^b SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CAMYLOFIN; DROTAVERINE; ROCIVERINE; SCOPOLAMINE BUTYL BROMIDE; SPASMOLYTIC AGENT; UNCLASSIFIED DRUG; VALETHAMATE BROMIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADVERSE EVENT; CLINICAL ASSESSMENT; DRUG EFFECT; DRUG SAFETY; EVIDENCE BASED MEDICINE; HUMAN; LABOR; LABOR MANAGEMENT; LABOR STAGE; META ANALYSIS; OBSTETRIC DELIVERY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; UTERINE CERVIX DILATATION; CHEMICALLY INDUCED; DRUG EFFECTS; FEMALE; LABOR STAGE 1; OBSTETRIC LABOR COMPLICATIONS; PREGNANCY; TACHYCARDIA;

FEMALE; HUMANS; LABOR STAGE, FIRST; OBSTETRIC LABOR COMPLICATIONS; PARASYMPATHOLYTICS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TACHYCARDIA;

EID: 84891678403     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009243.pub3     Document Type: Review

References (83)

1. Ajmera SK, Shah PK, Shinde GA. Comparative study of drotaverine vs. Valethamate in cervical phase of labour. Bombay Hospital Journal (http://www.bhj.org/journal/2006_4802_april/html/org_res_305-309.html) (accessed 16 December 2011).
2. Al Matari F. Is buscopan (hyoscine-N-butylbromide) effective in shortening labor? [abstract]. 31st British International Congress of Obstetrics and Gynaecology; 2007 July 4-6; London, UK. 2007:114.
3. Al Qahtani NH, Al Hajeri F. The effect of hyoscine butylbromide in shortening the first stage of labor: A double blind, randomized controlled trial. Therapeutics and Clinical Risk Management 2011;7:495-500.
4. Azari M, Mardi A, Dargahi R. The effect of combination atropine and hyoscine progress of delivery in primiparous women in Ardabil - Alavi Hospital 2008. Journal of Maternal-Fetal and Neonatal Medicine 2010;23(S1):226.
5. Batukan AC, Ozgun MT, Turkyilmaz C, Dolanbay M, Muderris II. Effect of valethamate bromide in acceleration of labor: a double-blind, placebo-controlled trial [Valetamat bromurun dogum eylemini hizlandirmadaki etkisi: Plasebo kontrollu, cift kor bir calisma.]. Journal of the Turkish German Gynecology Association Artemis 2006;7(3):202-5.
6. Cromi A, Ghezzi F, Agosti M, Uccella S, Piazza N, Serati M, et al.Use of an antispasmodic (Rociverine) to shorten the length of labor: a randomized, placebo-controlled trial. Acta Obstetricia et Gynecologica Scandinavica 2011;90(12):1371-8.
7. Dahal P, Banerjee B, Uprety DK, Das BP, Thakur A, Agrawal A. Comparative study of efficacy of drotaverine hydrochloride and valethamate bromide with control in first stage of labour. Health Renaissance 2013;11(1):38-42.
8. Gupta B, Nellore V, Mittal S. Drotaverine hydrochloride versus hyoscine-N-butylbromide in augmentation of labor. International Journal of Gynecology & Obstetrics 2008;100(3):244-7.
9. Khosla AH, Bala I, Dahiya K, Sangwan K. A comparative study of the efficacy of valethamate bromide with drotaverine in normal labor. Journal of Obstetrics and Gynecology of India 2003;53(6):568-70.
10. Kuruvila S, Jasper P, Peedicayil A, Mathai M. A randomized controlled trial of valethamate bromide in acceleration of labor. International Journal of Gynecology & Obstetrics 1992;38:93-6.
11. Madhu C, Mahavarkar S, Bhave S. A randomised controlled study comparing drotaverine hydrochloride and valethamate bromide in the augmentation of labour. Archives of Gynecology and Obstetrics 2010;282:11-5.
12. Makvandi S. The effect of hyoscine - N - butyl bromide suppository on labor pain and process in nuliparous women. IRCT Iranian Registry of Clinical Trials (www.irct.ir) (accessed 6 December 2010) 2010.
13. Mukaindo AM, Stones WR (Department of Obstetrics and Gynaecology, Aga Khan University Hospital Nairobi). Hyoscine-N-butylbromide for the acceleration of labor in first time parturients: a randomized, double-blind, placebo-controlled trial. Personal communication via email 24 October 2011.
14. Raghavan R. The effect of hyoscine butyl bromide on the first stage of labour in term pregnancies. BJOG: an international journal of obstetrics and gynaecology 2008;115(8):1064-5.
15. Samuels LA, Christie L, Roberts-Gittens B, Fletcher H, Frederick J. The effect of hyoscine butylbromide on the first stage of labour in term pregnancies. BJOG: an international journal of obstetrics and gynaecology 2007;114(12):1542-6.
16. Sekhavat L, Karbasi S, Fallah R, Mirowliai M. Effect of hyoscine butylbromide first stage of labour in multiparus women. African Health Sciences 2012;12(4):408-11.
17. Sharma JB, Pundir P, Kumar A, Murthy NS. Drotaverine hydrochloride vs. valethamate bromide in acceleration of labor. International Journal of Gynecology & Obstetrics 2001;74:255-60.
18. Singh KC, Jain P, Goel N, Saxena A. Drotaverine hydrochloride for augmentation of labor. International Journal of Gynecology & Obstetrics 2004;84:17-22.
19. Taskin O, Saade G, Belfort M, Moise K. The effect of narcotics and spasmolytics on cervical dilatation in labor: a randomized placebo-controlled study. American Journal of Obstetrics and Gynecology 1993;168:362.
20. Warke HS, Chauhan AR, Raut VS, Ingle KM. Efficacy of camylofin dihydrochloride in acceleration of labour: A randomised double blind trial. Bombay Hospital Journal 2003;45(3):420-3.
21. Yilmaz B, Kart C, Kelekci S, Gokturk U, Sut N, Tarlan N, et al.Meperidine versus valethamate bromide in shortening the duration of active labor. International Journal of Gynecology & Obstetrics 2009;107(2):126-9.
22. Aggarwal P, Zutshi V, Batra S. Role of hyoscine N-butyl bromide (HBB, Buscopan) as labor analgesic. Indian Journal of Medical Science 2008;62(5):179-84.
23. Akleh HE, Al-Jufairi ZA. Effect of hyoscine-N-bulyl bromide (Buscopan) in accelerating first stage of labor. Journal of the Bahrain Medical Society 2010;22(3):103-7.
24. Baracho HM, Kamat JR, Kunkalekar K, Jacob L. Hyoscine-N-Butylbromide (Buscopan) in acceleration of labour. Journal of Obstetrics and Gynaecology of India 1982;34:509-12.
25. Bhattacharaya P, Joshi SG. Acceleration of labour intramuscular "Buscopan" injection. Journal of Obstetrics and Gynaecology of India 1984;35:1014-7.
26. Chan DPC. The use of Buscopan during the first stage of labour. The Bulletin of the Hong Kong Chinese Medical 1963;15:69-71.
27. Demory JE, Firmin JM, Parot P. The value of magnesium pyrrolidone carboxylate in true cervix dystocia. A double blind vs placebo study. Revue Francaise de Gynecologie et d Obstetrique 1990;85:413-6.
28. De Nobrega-Correa H, Guerra-Velasquez M, Reyna-Villasmil E, Mejia-Montilla J, Reyna-Villasmil N, Torres-Cepeda D, et al.Effects of intravenous hyoscine butylbromide-oxytocin or oxytocin on the duration of labor in term pregnancies [Spanish] [Efectos del butil bromuro de hioscina-oxitocina u oxitocina intravenosos en la duracion del parto de embarazos a termino]. Progresos de Obstetricia y Ginecologia 2010;53(12):502-6.
29. Fouedjio JH, Ymele Fouelifack F, Kenfack B, Wache Sime LC, Nana NP, Temkou S, et al.Efficacité du phloroglucinol sur le raccourcissement de la phase active du travail à la maternité de l'Hôpital Central de Yaoundé, Cameroun. Clinics in Mother and Child Health 2012;9:C12502.
30. Guerresi E, Gori G, Beccari A, Farro M, Mazzanti C. Influence of spasmolytic treatment and amniotomy on delivery times: a factorial clinical trial. Clinical Therapeutics 1981;3(5):382-8.
31. Hamann GO. Avacan vs fortral. A controlled double blind investigation on parturient patients. Ugeskrift for Laeger 1972;134:2261-5.
32. Hao Y, Zhai GR, Duan AH. Effects of spasfon on course of labor. Chung-Hua Fu Chan Ko Tsa Chih [Chinese Journal of Obstetrics and Gynecology] 2004;39(9):606-8.
33. Kauppila O, Koistinen O, Vaalamo P. Drug-induced acceleration of labour. Trials of an Indan derivative in childbirth. Annales Chirurgiae et Gynaecologiae Fenniae 1970;59:85-9.
34. Kaur D, Kaur R. Comparison of drotaverine and epidosin in the first stage of labor. Journal of Obstetrics and Gynecology of India 2003;53(5):449-52.
35. Kaur D, Kaur A. "Anafortan" an old drug with its newer use in acceleration of labour [abstract]. 49th All India Congress of Obstetrics and Gynaecology; 2006 January 6-9; Cochin, Kerala State, India. 2006:59.
36. Malensek B. The influence of spasmoanalgetics on uterine activity. Jugoslavenska Ginekologija i Perinatologija 1985;25:75-9.
37. Manpreet K, Gouramba R, Jyothi K, Venkatesh S, Biradar R. A comparative study of hyoscine butylbromide versus drotaverine hydrochloride in first stage of labor. Journal of Obstetrics and Gynecology of India 2008;58(3):230-4.
38. Maritati V, Tanganelli E, Boccardo E, Camandona F, Pietrasanta R, Maganza C, et al.The use of sintropium bromide, a new spasmolytic, in obstetrics and gynecology. Minerva Ginecologica 1986;38(11):965-9.
39. Mishra SL, Toshniwal A, Banerjee R. Effect of drotaverine on cervical dilatation: a comparative study with epidosin (valethamate bromide). Journal of Obstetrics and Gynecology of India 2002;52(3):76-9.
40. Mortazavi F, Rakhshani MH. The effect of atropine, hyoscine and promethazine on the duration of labor stages and rate of labor progress in multiparous women. Journal of the Gorgan University of Medical Sciences 2004;6(2):92.
41. Rajkumar K, Vedavalli R. Drotaverine hydrochloride vs valethamate bromide for cervical dilatation in active phase of labour [abstract]. 49th All India Congress of Obstetrics and Gynaecology; 2006 January 6-9; Cochin, Kerala State, India. 2006:96.
42. Sirohiwal D, Dahiya K, Mandira DE. Efficacy of hyoscine-N-butyl bromide (Buscopan) suppositories as a cervical spasmolytic agent in labour. Australian and New Zealand Journal of Obstetrics and Gynaecology 2005;45:128-9.
43. Tabassum S, Afridi B, Aman Z. Phloroglucinol for acceleration of labour: double blind, randomized controlled trial. JPMA - Journal of the Pakistan Medical Association 2005;55(7):270-3.
44. Tripti N, Jyoti J. To compare and evaluate the efficacy and safety of drotaverine and valethamate bromide. Journal of Obstetrics and Gynaecology of India 2009;59(4):324-31.
45. Von Hagen H. Clinical trials with the spasmo-analgesic Spasdolsin in obstetrics (with application of a new methodology). Zentralblatt fur Gynakologie 1965;36:1201-9.
46. Accinelli G, Olivieri T, Vibelli C. The effectiveness of a new spasmolytic drug (DA 3177) during the active phase of labour. Acta Therapeutica 1978;4:19-27.
47. Ahmed LT, Merouana A, Nait B, Souiah N, Chenntouf M, Larbi LO. Antispasmodics in obstetrics: myth or reality [Les antispasmodiques en obstetrique: mythe ou realite]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1982;11(2):281-4.
48. Georges R, Aldahan F, Alwaeely F. The evaluation of the effect of buscopan (hyoscine-N-butyl bromide) on the duration of labour [abstract]. 31st British International Congress of Obstetrics and Gynaecology; 2007 July 4-6; London, UK. 2007:102.
49. Rajani M, Umadevi N, Jayasree S. Efficacy of valethamate bromide on cervical dilatation during the labour in comparison with placebo. 54th All India Congress of Obstetrics and Gynaecology; 2011 January 5-9; Hyderabad, Andhra Pradesh, India. 2011:141.
50. Ranka PR, Hishikar VA. Effect of drotaverine hydrochloride on normal labour - a randomised study. Journal of Obstetrics and Gynecology of India 2002;52(6):28-30.
51. Recto CP, Co TV, Clemente V. The effect of hyoscine-n-butylbromide on the first stage of labor: a clinical trial. Acta Obstetricia et Gynecologica Scandinavica 1997;76 Suppl(167:1):45.
52. Roy A, Patra KK, Mukhopadhyay S, Guha S. Study of drotaverine on first stage of labour and pregnancy outcome. Journal of the Indian Medical Association 2007;105(8):450.
53. Zagami SE, Golmakani N, Saadatjoo SAR, Dadgar S, Baghbani B. Comparison of effects of hyoscine N-butyl bromide and promethazine on length of active phase of first stage of labor. Iranian Journal of Obstetrics, Gynecology and Infertility 2012;15(6):16-21.
54. Movahed F. The effect of hyoscin on duration on the first stage of labor in term pregnancies. IRCT Iranian Registry of Clinical Trials (www.irct.ir) (accessed 6 December 2010) 2010.
55. Brown HC, Paranjothy S, Dowswell T, Thomas J. Package of care for active management in labour for reducing caesarean section rates in low-risk women. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD004907.pub2]
56. Buhimschi CS, Buhimschi IA, Malinow AM, Saade GR, Garfield RE, Weiner CP. The forces of labour. Fetal and Maternal Medicine Review 2003;14(4):273-307.
57. Clark SL, Simpson KR, Knox GE, Garite TJ. Oxytocin: new perspectives on an old drug. American Journal of Obstetrics and Gynecology 2009;200:35.e1-35.e6.
58. Daftary SN, Desai SV, Thanawala U, Bhide A, Levi J, Patki A, et al.Programmed labor - indegenous protocol to optimize labor outcome. South Asian Federation of Obstetrics and Gynecology 2009;1(1):61-4.
59. Dencker A, Berg M, Bergvist L, Ladfors L, Thorsen LS, Lilja H. Early versus delayed oxytocin augmentation in nulliparous women with prolonged labour - a randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology 2009;116:530-6.
60. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34.
61. Gibbon CJ. South African Medicines Formulary. 6th Edition. Cape Town: Health and Medical Publishing, 2005.
62. Gitanjali B. Valethamate bromide: Is there any proof of efficacy and safety for its use in labor?. Journal of Pharmacology and Pharmacotherapeutics 2010;1(1):2-3.
63. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al.GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64:383-94.
64. Harbord RM, Egger M, Sterne JA. A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints. Statistics in Medicine 2006;25(20):3443-57.
65. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
66. Khan KS, Wojdyla D, Say L, Gülmezoglu M, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:1066-74.
67. Lavender T, Hart A, Smyth RMD. Effect of partogram use on outcomes for women in spontaneous labour at term. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD005461.pub2]
68. Leppert PC. Anatomy and physiology of cervical ripening. Clinical Obstetrics and Gynecology 1995;38:267-79.
69. Neal JL, Lowe NK, Patrick TE, Cabbage LA, Corwin EJ. What is the slowest-yet-normal cervical dilatation rate among nulliparous women with spontaneous labor onset?. Journal of Obstetric, Gynecologic, and Neonatal Nursing: JOGNN 2010;39:361-9.
70. Neilson JP, Lavender T, Quenby S, Wray S. Obstructed labour. British Medical Bulletin 2003;67:191-204.
71. O'Driscoll K, Stronge JM, Minogue M. Active management of labour. British Medical Journal 1973;3:135-7.
72. O'Driscoll K. Active management of labour. True purpose has been misunderstood. BMJ 1994;309(6960):1015.
73. Ramsay C. How do you include trials with more than two groups into a single meta-analysis?. FAQs: methodology in the Cochrane Effective Practice and Organisation of Care Group 2003.
74. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
75. Romics I, Molnár DL, Timberg G, Mrklic B, Jelakovic B, Köszegi G, et al.The effect of drotaverine hydrochloride in acute colicky pain caused by renal and ureteric stones. BJU International 2003;92(1):92-6.
76. Samuels L. Pharmacotherapy update: hyoscine butylbromide in the treatment of abdominal spasms. Clinical Medicine Insights: Therapeutics 2009;1:647-55.
77. Sommers De K. Sommers' Pharmacology. Pretoria: UP Drukkers, 2002.
78. Thirunavukkarasu AB, Vijayan S. Valethamate bromide: Conflicting evidence and continuing use. Journal of Pharmacology and Pharmacotherapeutics 2010.
79. Wei S, Wo BL, Xu H, Luo ZC, Roy C, Fraser WD. Early amniotomy and early oxytocin for prevention of, or therapy for, delay in first stage spontaneous labour compared with routine care. Cochrane Database of Systematic Reviews 2009, Issue 2. [DOI: 10.1002/14651858.CD006794.pub2]
80. World Health Organization maternal health and safe motherhood programme. World Health Organization partograph in management of labour. Lancet 4 June 1994;343(8910):1399-404.
81. World Health Organization. Trends in maternal mortality: 1990-2008. Estimates developed by WHO, UNICEF, UNFPA and the World Bank. http://www.who.int/reproductivehealth/publications/monitoring/9789241500265/en/index.html (accessed 9 February 2010).
82. Yuel VI, Kaur V, Kaur D. Programmed labor for optimizing labor and delivery. JK Science 2008;10(2):62-4.
83. Rohwer AC, Khondowe O, Young T. Antispasmodics for labour. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD009243.pub2]